|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 22760986.4 (espacenet) (Federated) (European Patent Register), 20220805 | | Patent/reg. no. and date | DK/EP 4203919, 20240131 | | Publication date | 20230705 | | Priority no. and date | EP 21189990, 20210805 | | EP pub. no. and date |
EP 4203919 20230705 | | Effective date | | | Applicant/owner | Pharvaris GmbH, Grafenauweg 8
6300 Zug, CH | | Applicant ref. no. | 1704186 | | Inventor | GIBSON, Christoph,
6300 Zug, CH | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4709 (2006.01) , A61K 9/107 (2006.01) , A61K 9/48 (2006.01) , A61P 7/10 (2006.01) | | Title | LIPIDBASERET SAMMENSÆTNING TIL ORAL ADMINISTRATION AF BRADYKININ-B2-RECEPTORANTAGONISTER | | Int. application no. | EP2022072049 | | Int. publication no. | WO2023012322 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
